Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
- 11 resultaten
Zoekresultaten
-
2024
Activated cDCs by anti-CD40 agonist therapy induce anti-tumor effectsin Multiple Myeloma
Verheye, E., Kancheva, D., Satilmis, H., Vandewalle, N., Fan, R., Bardet, P., Clappaert, E., Vanderkerken, K., De Veirman, K. & Laoui, D., 2024, (Unpublished).Onderzoeksoutput: Poster
-
Adrenergic signaling activates the tumor immune microenvironment in Multiple Myeloma
Satilmis, H., Verheye, E., Vandewalle, N., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 1 feb 2024, (Unpublished).Onderzoeksoutput: Poster
-
Adrenergic signaling activates the tumor immune microenvironment in Multiple Myeloma
Satilmis, H., Verheye, E., Vandewalle, N., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 30 mei 2024, (Unpublished).Onderzoeksoutput: Poster
-
Adrenergic signaling activates the tumor immune microenvironment in Multiple Myeloma
Satilmis, H., Verheye, E., Vandewalle, N., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 23 okt 2024, (Unpublished).Onderzoeksoutput: Poster
-
A Single-Cell Transcriptomic Map of the Murine and Human Multiple Myeloma Immune Microenvironment across disease stages
Verheye, E., Kancheva, D., Satilmis, H., Vandewalle, N., Fan, R., Bardet, P., Clappaert, E., Verstaen, K., De Becker, A., Vanderkerken, K., De Veirman, K. & Laoui, D., 2024, (Unpublished).Onderzoeksoutput: Poster
-
2023
Activated cDCs by aCD40 therapy induce anti-tumor effects in Multiple Myeloma
Verheye, E., Kancheva, D., Satilmis, H., Vandewalle, N., Fan, R., Bardet, P., Clappaert, E., Vanderkerken, K., De Veirman, K. & Laoui, D., 2023, (Unpublished).Onderzoeksoutput: Poster
-
Elevated LAG-3 expression in plasma cells and lymphoid subpopulations at distinct stages of Multiple Myeloma disease progression
Satilmis, H., Vandewalle, N., Verheye, E., Fan, R., De Bruyne, E., Menu, E., Devoogdt, N., Vanderkerken, K., Breckpot, K. & De Veirman, K., 29 sep 2023, (Unpublished).Onderzoeksoutput: Poster
-
2022
The multifaceted anti-cancer effects of the immunomodulator Tasquinimod in Multiple Myeloma
Fan, R., Verheye, E., Satilmis, H., Vandewalle, N., De Bruyne, E., Menu, E., De Beule, N., Hose, D., Vanderkerken, K., Breckpot, K., Maes, K. & De Veirman, K., 4 feb 2022.Onderzoeksoutput: Poster
-
2021
Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo
Fan, R., Satilmis, H., Vandewalle, N., De Bruyne, E., Menu, E., D Chantry, A., Evans, H., Törngren, M., Eriksson, H., Breckpot, K., Maes, K., Vanderkerken, K. & De Veirman, K., 23 nov 2021, blz. 1594-1594. 1 blz.Onderzoeksoutput: Poster
-
The impact of beta-blockers on Multiple Myeloma cell survival
Satilmis, H., Vandewalle, N., Fan, R., Oudaert, I. & De Veirman, K., 3 mrt 2021.Onderzoeksoutput: Poster
-
2020
The impact of beta-blockers on Multiple Myeloma cell survival
Satilmis, H., Vandewalle, N., Fan, R., Oudaert, I. & De Veirman, K., 29 jan 2020.Onderzoeksoutput: Poster